Showing 1–10 of 10 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Helen Ayles, Professor
…tive evidence of the effectiveness of scaled up combination TB/HIV prevention interventions on TB. The second output will improve understanding of the best ways to measure the impact of public health interventions on TB burden. This is a unique opportunity to assess the impact o…
Gudeta Imana Jaleta, Vinodhini Rajamanickam, Kifle Woldemichael
…ong PLHIV under follow-up, Health care providers (HCPs) and TB/HIV coordinators working in Jimma University Specialized Hospital (JUSH) ART clinic. Methods: An Institution based mixed cross-sectional study was conducted in JUSH ART clinic. Adult HIV infected patients were enrolle…
Irini Sereti, M.D.
…ies are needed to characterize the spectrum of responses to TB/HIV co-infection, and how these responses correlate with clinical data. We propose a cross-sectional cohort study, to be conducted in both the US and in China, to identify blood mRNA expression profiles distinguishin…
M. S. Grabovskaya, Л. Н. Мотанова, D.А. Kudlаy, Н. П. Докторова
We analyzed the epidemic situation of TB/HIV co-infection in Primorsky Krai in 2008–2023 and revealed the tendency towards escalation of TB/HIV co-infection, which required a detailed analysis and improved effectiveness of preventive measures against TB infection in HIV-positive …
Mareli Claassens, Chawangwa Modongo, Tadesse Kassaye, Gunar Guenther, Emmanuel Nepolo, et al.
…ribute to the growing literature on Covid-19 in high burden TB/HIV settings, and to the rationale behind universal active TB screening at primary healthcare facilities.
Grant Theron, PhD, Balthazar Nyombi, PhD, Kidist Bobosha, PhD, Carol Holm-Hansen, PhD
…n, SeroSelectTB is sensitive among adults co- infected with TB/HIV. Primary objective of field trial is to evaluate the diagnostic delay, measured as the time from TB diagnostic to TB treatment initiation between two groups of patients: those who were screened with SeroSelectTB …
Charisse Mandimika, Gerald Friedland
… advances and challenges in the prevention and treatment of TB/HIV disease. Drug-susceptible and drug-resistant tuberculosis (TB) and human immunodeficiency virus (HIV) epidemics are a consequence of reactivation of latent TB infection (LTBI), treatment-related amplification of T…
М. В. Синицын, Evgeniy Belilovsky, E. M. Bogorodskaya, Borisov Se, D.А. Kudlаy, et al.
…tract Background The difficult epidemic situation caused by TB/HIV co-infection and, accordingly, the need to strengthen measures for the prevention of tuberculosis among HIV patients, identified the need to create a model of collaborating tuberculosis management facilities and A…
Maphe Mthembu, Kathryn Bowman, Leela Davies, Sharon Khuzwayo, Lusanda Mazibuko, et al.
… also funded in part by the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) through a grant [DEL-15-006] by the Wellcome Trust and the UK Foreign, Commonwealth & Development Office, with support from the Developing Excellence in Leadership, Training and Sc…
Marc Lipman, MD
…ence of LTBI (with positive TST or IGRA) will be invited to TB/HIV clinic and quality of life scores recorded as part of the study. Research Questions: 1. To determine the feasibility, yield and cost--effectiveness of testing for M. tuberculosis infection in UK HIV infected ind…